 Prognosis AZT myopathy myopathy zidovudine AZT common characterized prognosis patients HIV infection necrotizing myopathy AZT months myalgia proximal muscle weakness Serum CK times normal EMG active myopathy scattered granular degenerating fibers scant inflammation pattern consistent toxic myopathy patients patients HIV-related inflammatory myopathy histologic differences AZT Strength normal normal strength persistent weakness CK normal follow-up EMG reduced fibrillation density patients findings need early diagnosis reversible myopathy